source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
PubMed |
17192049 |
Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer.
CYP1A1 activates envi |
1.27 KB |
2015-11-23 |
|
27 |
|
16 |
2021-12-05
|
PubMed |
17194457 |
Behavioral effects of pubertal anabolic androgenic steroid exposure in male rats with low serotonin. |
1.72 KB |
2015-12-24 |
|
24 |
|
41 |
2021-12-05
|
PubMed |
17221831 |
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzhei |
1.59 KB |
2015-11-23 |
|
28 |
|
32 |
2021-12-05
|
PubMed |
17255138 |
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk excee |
1.87 KB |
2015-12-27 |
|
24 |
|
53 |
2021-12-05
|
PubMed |
17395743 |
Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a po |
1.54 KB |
2015-11-23 |
|
28 |
|
18 |
2021-12-05
|
PubMed |
17549393 |
A novel IRF6 nonsense mutation (Y67X) in a German family with Van der Woude syndrome.
Van der Woude |
1.29 KB |
2015-11-23 |
|
27 |
|
26 |
2021-12-05
|
PubMed |
15200408 |
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for diseas |
2.45 KB |
2015-11-19 |
|
27 |
|
45 |
2021-12-05
|
PubMed |
15233872 |
Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in r |
1010 Bytes |
2015-11-22 |
|
23 |
|
25 |
2021-12-05
|
PubMed |
15241482 |
Paraoxonase 1 polymorphisms and survival.
The antioxidant enzyme paraoxonase 1 (PON1) has previously |
1.61 KB |
2015-11-19 |
|
26 |
|
24 |
2021-12-05
|
PubMed |
15266215 |
Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory a |
1.92 KB |
2015-11-22 |
|
23 |
|
45 |
2021-12-05
|